Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00196_DB00540> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00196_DB00540 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00196_DB00540 label "DDI between Fluconazole and Nortriptyline - Fluconazole may increase the effect and toxicity of the tricyclic antidepressant, nortriptyline, by decreasing its metabolism. Additive QTc-prolonging effects may also occur. Monitor for changes in the therapeutic and adverse effects of nortriptyline if fluconazole is initiated, discontinued or dose changed. Monitor for the development of torsades de pointes during concomitant therapy. [drugbank_resource:DB00196_DB00540]" assertion.
- drugbank_resource:DB00196_DB00540 identifier "drugbank_resource:DB00196_DB00540" assertion.
- drugbank_resource:DB00196_DB00540 title "DDI between Fluconazole and Nortriptyline - Fluconazole may increase the effect and toxicity of the tricyclic antidepressant, nortriptyline, by decreasing its metabolism. Additive QTc-prolonging effects may also occur. Monitor for changes in the therapeutic and adverse effects of nortriptyline if fluconazole is initiated, discontinued or dose changed. Monitor for the development of torsades de pointes during concomitant therapy." assertion.